First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MHV370, a Dual Inhibitor of Toll-Like Receptors 7 and 8, in Healthy Adults.
Eur J Drug Metab Pharmacokinet
; 48(5): 553-566, 2023 Sep.
Article
in En
| MEDLINE
| ID: mdl-37532923
Full text:
1
Database:
MEDLINE
Main subject:
Toll-Like Receptor 7
/
Toll-Like Receptor 8
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Animals
/
Humans
Language:
En
Journal:
Eur J Drug Metab Pharmacokinet
Year:
2023
Type:
Article
Affiliation country:
Switzerland